Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer

BACKGROUND: People with urothelial carcinoma of the bladder are at risk for recurrence and progression following transurethral resection of a bladder tumour (TURBT). Mitomycin C (MMC) and Bacillus Calmette‐Guérin (BCG) are commonly used, competing forms of intravesical therapy for intermediate‐ or h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Schmidt, Stefanie, Kunath, Frank, Coles, Bernadette, Draeger, Desiree Louise, Krabbe, Laura‐Maria, Dersch, Rick, Kilian, Samuel, Jensen, Katrin, Dahm, Philipp, Meerpohl, Joerg J
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2020
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956215/
https://ncbi.nlm.nih.gov/pubmed/31912907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011935.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky